Healthtech Startups

Evidence-based teletherapy platform addressing alcohol use disorder.

1 investor

Anocis is a pharmaceutical drug discovery company focused on early-stage development in neuroscience, particularly ion channel research. The company serves pharmaceutical and biotech clients seeking collaborative drug discovery services and technologies.

1 investor

Anoria makes a wearable device designed to help users read and understand their emotions. The product targets individuals interested in emotional intelligence and personal emotional awareness.

1 investor

ANRis develops nucleic acid therapeutics using proprietary SNPD-siRNA technology for drug discovery and treatment delivery in medical and pharmaceutical applications.

1 investor

Ansana develops sterilization process management and control solutions for healthcare and pharmaceutical organizations, focusing on patient safety and operational efficiency.

1 investor

Anser Bio is a biotech company focused on cancer research and drug development, working on areas such as exosome-based therapeutics, protein purification, and cell technologies. The team combines expertise in immuno-oncology, cell therapy, and translational R&D.

1 investor

Antabio is a clinical-stage biopharmaceutical company developing novel antibacterial treatments for drug-resistant, Gram-negative bacterial infections identified as critical priorities by the WHO and CDC, with a focus on life-threatening hospital-acquired infections. Its lead program, Meropenem-Pilabactam, is a β-lactam/β-lactamase inhibitor combination for treating multidrug-resistant infections in hospital wards and ICUs.

1 investor

1 investor

Antaros Medical is a development partner to the pharmaceutical industry that uses medical imaging to provide evidence-based decision support during clinical drug development. It combines imaging technology with expertise in drug development and disease mechanisms.

1 investor

Antelope Surgical Solutions develops multimodal small-molecule radioligand agents that bind to cancer cells for diagnostic, radiotherapeutic, and fluorescence-guided surgical use, making tumor margins visible to surgeons during operations. The company operates a GMP manufacturing facility with robotic high-throughput synthesis and has received its first FDA IND clearance for its lead agent.

1 investor

Anthriq develops the Human Body API, a hardware and software platform that reads and writes human biosignals and psychophysiological data to enable developers to build brain-computer interface and human-computer interaction products. The company provides a full-stack foundation for innovators working on neurotech and biotech applications.

1 investor

AnthroMed Education is a staffing and clinical support practice providing speech-language pathologists, social workers, counselors, and occupational therapists to school-based special education programs. The company focuses on professional development and therapeutic services delivery within educational settings.

1 investor

Antidote connects patients with relevant clinical trials and helps trial sponsors recruit participants through precision matching, aiming to reduce delays in medical research. It operates in the clinical trial recruitment space, serving both patients seeking trials and research sponsors filling studies.

1 investor

Antser Group provides technology-enabled services and solutions for the health and social care sectors, including child protection, adoption, and family support. The company serves local authorities and sector organizations across England, combining software platforms and virtual reality applications to improve outcomes for children, families, and vulnerable adults.

1 investor

AOBiome Therapeutics is a late-stage biotechnology company developing microbiome-based treatments for inflammatory skin conditions such as atopic dermatitis and pruritus. Its lead candidate, B244, uses a single strain of Ammonia Oxidizing Bacteria to moderate immune response by simultaneously down-regulating multiple inflammatory markers (IL-4, IL-5, IL-13, IL-31).

1 investor

AOK is a German public health insurance provider offering statutory health coverage with supplementary services including bonus programs, preventive health courses, and doctor programs to individual customers.

1 investor

APA Medical supplies home medical equipment and supplies — including lift chairs, mobility aids, bathroom and bedroom safety items, incontinence products, and everyday care supplies — with delivery, installation, insurance coordination, and resupply services. It serves individuals managing health and mobility needs at home, primarily in the Minneapolis, Minnesota area.

1 investor

Apacheta developed a flexible mobile application framework used for field service and delivery workflow applications. It was acquired by Brightree LLC in 2018 and its offering is now branded as Brightree Mobile Delivery, serving HME/DME (home medical equipment) organizations.

1 investor

Apara Autism Center delivers applied behavior analysis (ABA) therapy and life skills training for children with autism in a clinical setting. The center provides comprehensive support to families through collaborative treatment plans, medical coordination, and community resources to help navigate autism diagnosis and care.

1 investor

Aparito provides Atom5, an electronic clinical outcome assessment platform that collects patient data through video assessments, patient-reported outcomes, telemedicine, wearables, and digital consent for clinical research sponsors. The platform supports multi-device data capture across iOS, Android, and web, with analytics and FDA/GDPR/HIPAA compliance for hybrid and decentralized clinical studies.

1 investor

Applied BioCode develops multiplex diagnostic testing products for infectious disease detection using proprietary barcoded magnetic bead technology. The company serves clinical and research markets with panels that detect bacterial and fungal pathogens and antimicrobial resistance markers.

1 investor

Apeiron Therapeutics is a biotech company developing small-molecule therapeutics with a focus on immuno-oncology and oncology drug discovery. The company operates across the Chinese and global healthcare markets, spanning target identification, medicinal chemistry, and clinical development.

1 investor

APEX is a Japanese medical device company that develops and supplies safe, innovative products and services to hospitals and customers. The company focuses on healthcare advancement while maintaining ethical business practices.

1 investor

Apex Infusion is a California-based provider of infusion therapy delivered in private suites, at home, and in physician offices, along with integrated pharmacy services. It serves patients and referring healthcare providers with clinical and administrative support for infusion treatments.

1 investor